ArticleFrontiers in cardiovascular medicine2022

GSK-J4, a Specific Histone Lysine Demethylase 6A Inhibitor, Ameliorates Lipotoxicity to Cardiomyocytes

Kai Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.